Comparison of chimeric mouse-human and humanized anti-CD25 monoclonal antibodies for steroid-refractory acute graft-versus-host disease.

Front Immunol · 2025 · PMC12808378 · PMID 41550930

Europe PMC DOI

hedged sentence

0.0830

closest p · 1.7× alpha

0.0830

boldest claim

The sentences

did not reach statistical significancep=0.083so close (0.05 < p ≤ 0.1)

In our cohort, a high Minnesota risk score was significantly associated with failure to achieve CR on day 28 in patients treated with anti-CD25 monoclonal antibodies in the univariate logistic regression analysis (p=0.01), however, this association did not reach statistical significance in the multivariate model (p=0.083).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.